Literature DB >> 20808235

High relaxivity magnetic resonance imaging contrast agents. Part 1. Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes.

Stéphane Dumas1, Vincent Jacques, Wei-Chuan Sun, Jeffrey S Troughton, Joel T Welch, Jaclyn M Chasse, Heribert Schmitt-Willich, Peter Caravan.   

Abstract

RATIONALE AND
OBJECTIVES: The donor atoms that bind to gadolinium in contrast agents influence inner-sphere water exchange and electronic relaxation, both of which determine observed relaxivity. The effect of these molecular parameters on relaxivity is greatest when the contrast agent is protein bound. We sought to determine an optimal donor atom set to yield high relaxivity compounds.
METHODS: A total of 38 gadolinium-1,4,7,10-tetraazacyclo-dodecane-N,N',N'',N'''-tetraacetato derivatives were prepared and relaxivity was determined in the presence and absence of human serum albumin as a function of temperature and magnetic field. Each compound had a common albumin-binding group and differed only by substitution of different donor groups at one of the macrocycle nitrogens. Oxygen-17 isotope relaxometry at 7.05 T was performed to estimate water exchange rates.
RESULTS: Changing a single donor atom resulted in changes in water exchange rates ranging across 3 orders of magnitude. Donor groups increased water exchange rate in the order: phosphonatephenolate > α-substituted acetate > acetate > hydroxamatesulfonamide > amidepyridylimidazole. Relaxivites at 0.47 and 1.4 T, 37°C, ranged from 12.3 to 55.6 mM(-1)s(-1) and from 8.3 to 32.6 mM(-1)s(-1) respectively. Optimal relaxivities were observed when the donor group was an α-substituted acetate. Electronic relaxation was slowest for the acetate derivatives as well.
CONCLUSIONS: Water exchange dynamics and relaxivity can be predictably tuned by choice of donor atoms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20808235      PMCID: PMC3021469          DOI: 10.1097/RLI.0b013e3181ee5a9e

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  42 in total

1.  Synthesis, relaxometric and photophysical properties of a new pH-responsive MRI contrast agent: the effect of other ligating groups on dissociation of a p-nitrophenolic pendant arm.

Authors:  Mark Woods; Garry E Kiefer; Simon Bott; Aminta Castillo-Muzquiz; Carrie Eshelbrenner; Lydie Michaudet; Kenneth McMillan; Siva D K Mudigunda; Doug Ogrin; Gyula Tircsó; Shanrong Zhang; Piyu Zhao; A Dean Sherry
Journal:  J Am Chem Soc       Date:  2004-08-04       Impact factor: 15.419

2.  How does internal motion influence the relaxation of the water protons in Ln(III)DOTA-like complexes?

Authors:  Frank A Dunand; Alain Borel; André E Merbach
Journal:  J Am Chem Soc       Date:  2002-01-30       Impact factor: 15.419

3.  The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates.

Authors:  Peter Caravan; Normand J Cloutier; Matthew T Greenfield; Sarah A McDermid; Stephen U Dunham; Jeff W M Bulte; John C Amedio; Richard J Looby; Ronald M Supkowski; William DeW Horrocks; Thomas J McMurry; Randall B Lauffer
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

4.  In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms.

Authors:  Romain Bazeli; Michèle Coutard; Benjamin Daumas Duport; Eric Lancelot; Claire Corot; Jean-Pierre Laissy; Didier Letourneur; Jean-Baptiste Michel; Jean-Michel Serfaty
Journal:  Invest Radiol       Date:  2010-10       Impact factor: 6.016

5.  Lanthanide(III) complexes of a mono(methylphosphonate) analogue of H4dota: the influence of protonation of the phosphonate moiety on the TSAP/SAP isomer ratio and the water exchange rate.

Authors:  Jakub Rudovský; Petr Cígler; Jan Kotek; Petr Hermann; Pavel Vojtísek; Ivan Lukes; Joop A Peters; Luce Vander Elst; Robert N Muller
Journal:  Chemistry       Date:  2005-04-08       Impact factor: 5.236

6.  pH-dependent modulation of relaxivity and luminescence in macrocyclic gadolinium and europium complexes based on reversible intramolecular sulfonamide ligation.

Authors:  M P Lowe; D Parker; O Reany; S Aime; M Botta; G Castellano; E Gianolio; R Pagliarin
Journal:  J Am Chem Soc       Date:  2001-08-08       Impact factor: 15.419

7.  A high-frequency EPR study of frozen solutions of Gd(III) complexes: straightforward determination of the zero-field splitting parameters and simulation of the NMRD profiles.

Authors:  Meriem Benmelouka; Johan Van Tol; Alain Borel; Marc Port; Lothar Helm; Louis Claude Brunel; André E Merbach
Journal:  J Am Chem Soc       Date:  2006-06-21       Impact factor: 15.419

8.  Towards the rational design of MRI contrast agents: a practical approach to the synthesis of gadolinium complexes that exhibit optimal water exchange.

Authors:  Mark Woods; Mauro Botta; Stefano Avedano; Jing Wang; A Dean Sherry
Journal:  Dalton Trans       Date:  2005-09-21       Impact factor: 4.390

9.  Synthesis and evaluation of a high relaxivity manganese(II)-based MRI contrast agent.

Authors:  Jeffrey S Troughton; Matthew T Greenfield; Jaclyn M Greenwood; Stéphane Dumas; Andrea J Wiethoff; Jufeng Wang; Marga Spiller; Thomas J McMurry; Peter Caravan
Journal:  Inorg Chem       Date:  2004-10-04       Impact factor: 5.165

10.  The effect of the amide substituent on the biodistribution and tolerance of lanthanide(III) DOTA-tetraamide derivatives.

Authors:  Mark Woods; Peter Caravan; Carlos F G C Geraldes; Matthew T Greenfield; Garry E Kiefer; Mai Lin; Kenneth McMillan; M Isabel M Prata; Ana C Santos; Xiankai Sun; Jufeng Wang; Shanrong Zhang; Piyu Zhao; A Dean Sherry
Journal:  Invest Radiol       Date:  2008-12       Impact factor: 6.016

View more
  29 in total

1.  Enhancing T1 magnetic resonance imaging contrast with internalized gadolinium(III) in a multilayer nanoparticle.

Authors:  Valeria S Marangoni; Oara Neumann; Luke Henderson; Caterina C Kaffes; Hui Zhang; Runmin Zhang; Sandra Bishnoi; Ciceron Ayala-Orozco; Valtencir Zucolotto; James A Bankson; Peter Nordlander; Naomi J Halas
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

2.  Insulin Hexamer-Caged Gadolinium Ion as MRI Contrast-o-phore.

Authors:  Steven K Taylor; Timothy H Tran; Michael Z Liu; Paul E Harris; Yanping Sun; Sachin R Jambawalikar; Liang Tong; Milan N Stojanovic
Journal:  Chemistry       Date:  2018-07-04       Impact factor: 5.236

3.  MRI study of subconjunctival and intravitreal injections.

Authors:  S Kevin Li; Jinsong Hao; Hongshan Liu; Jing-huei Lee
Journal:  J Pharm Sci       Date:  2012-03-30       Impact factor: 3.534

4.  Structure - relaxivity relationships among targeted MR contrast agents.

Authors:  Peter Caravan; Zhaoda Zhang
Journal:  Eur J Inorg Chem       Date:  2012-04       Impact factor: 2.524

5.  Contrast agents for MRI: 30+ years and where are we going?

Authors:  Valérie C Pierre; Matthew J Allen; Peter Caravan
Journal:  J Biol Inorg Chem       Date:  2014-01-11       Impact factor: 3.358

6.  Eu(II)-containing cryptates as contrast agents for ultra-high field strength magnetic resonance imaging.

Authors:  Joel Garcia; Jaladhar Neelavalli; E Mark Haacke; Matthew J Allen
Journal:  Chem Commun (Camb)       Date:  2011-11-02       Impact factor: 6.222

7.  Facile synthesis of Gd-doped CdTe quantum dots with optimized properties for optical/MR multimodal imaging.

Authors:  Zizhen Li; Ali Dergham; Holly McCulloch; Yubo Qin; Xiuying Yang; Jingchang Zhang; Xudong Cao
Journal:  J Biol Inorg Chem       Date:  2017-09-01       Impact factor: 3.358

Review 8.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

9.  Gd(DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development.

Authors:  Eszter Boros; Miloslav Polasek; Zhaoda Zhang; Peter Caravan
Journal:  J Am Chem Soc       Date:  2012-11-16       Impact factor: 15.419

10.  Characterization of estrogen-receptor-targeted contrast agents in solution, breast cancer cells, and tumors in vivo.

Authors:  Adi Pais; Inbal Eti Biton; Raanan Margalit; Hadassa Degani
Journal:  Magn Reson Med       Date:  2012-08-10       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.